{"count":6,"index":{"built_at":"2026-07-26T23:26:02.190722+00:00","public_records":55311,"revision":"dd062d35e28958eea147558b"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: ApoB in the context of longevity"},"results":[{"answer":"ApoB (Apolipoprotein B) is a core component of atherogenic lipoproteins (LDL, VLDL) and is considered one of the strongest predictors of cardiovascular events. In longevity research, ApoB is relevant because elevated levels are directly linked to atherosclerosis, heart attack, and stroke – diseases that shorten lifespan. The evidence is human-strong: numerous prospective cohort studies and Mendelian randomization analyses demonstrate a causal relationship between ApoB and cardiovascular mortality. Unlike LDL cholesterol alone, ApoB captures the total number of atherogenic particles and is often more informative. The provided context lacks direct information on ApoB, so this answer relies on established scientific knowledge. For longevity, a low ApoB level (< 0.9 g/L in high-risk patients) is desirable, but always within the overall risk profile. Caveat: single measurements can be affected by inflammation or metabolic states; clinical decisions should be based on multiple values. MyBody-X offers ApoB in its blood test – the measurement is validated, but interpretation should be done by a physician.","area":"gesundheit","canonical_id":"gesundheit:canonical-e517d10c588917afa74577ed","id":"public-6156a110f62af31cf6434cff","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of longevity","score":24.54301762,"snippet":"ApoB (Apolipoprotein B) is a core component of atherogenic lipoproteins (LDL, VLDL) and is considered one of the strongest predictors of cardiovascular events. In longevity research, ApoB is relevant because elevated levels are directly linked to atherosclerosis, heart attack, and stroke – diseases that shorten lifespan. The evidence is human-strong: numerous prospective cohort studies and Mendelian randomization analyses demonstrate a causal relationship between ApoB and cardiovascular mortality. Unlike LDL cholesterol alone, ApoB captures the total number of atherogenic particles and is often more informative. The provided context lacks direct information on ApoB, so this answer relies on ","sources":[],"title":"Evidence check: ApoB in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6156a110f62af31cf6434cff/evidence-check-apob-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (apolipoprotein B) is a core component of atherogenic lipoproteins (LDL, VLDL) and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. In longevity research, ApoB is indirectly relevant: elevated levels promote atherosclerosis, reduce healthy lifespan, and are associated with increased mortality. However, ApoB is not a direct longevity marker but a risk factor that must be interpreted in the context of diet, exercise, and genetics. Direct-to-consumer tests often measure LDL-C rather than ApoB. The evidence for ApoB as a surrogate endpoint is strong (human-observational, Mendelian randomization), but measuring it alone without other lipid parameters and lifestyle factors is insufficient for longevity assessment. Caveat: No randomized trials have shown that lowering ApoB directly extends lifespan; the benefit comes from reducing cardiovascular events.","area":"gesundheit","canonical_id":"gesundheit:canonical-8db73a48c1bd8e2ee072d903","id":"public-6b1599819c844b731203ae30","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of Langlebigkeit","score":24.25131195,"snippet":"ApoB (apolipoprotein B) is a core component of atherogenic lipoproteins (LDL, VLDL) and is considered a stronger predictor of cardiovascular risk than LDL cholesterol alone. In longevity research, ApoB is indirectly relevant: elevated levels promote atherosclerosis, reduce healthy lifespan, and are associated with increased mortality. However, ApoB is not a direct longevity marker but a risk factor that must be interpreted in the context of diet, exercise, and genetics. Direct-to-consumer tests often measure LDL-C rather than ApoB. The evidence for ApoB as a surrogate endpoint is strong (human-observational, Mendelian randomization), but measuring it alone without other lipid parameters and ","sources":[],"title":"Evidence check: ApoB in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6b1599819c844b731203ae30/evidence-check-apob-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Your question about an APOB variant in the context of longevity is important. APOB encodes apolipoprotein B, a core component of LDL particles. Genetic variants in APOB can affect LDL clearance and thus modulate cardiovascular risk. However, effect sizes for common SNPs are generally small – they explain only a fraction of the variance. Crucially, a positive finding in a consumer test does not automatically indicate a pathogenic mutation. Many listed 'risk variants' are clinically benign or of uncertain significance. The evidence is human-strong, but based on population-wide association studies, not individual prediction. For your longevity, a fasting lipid panel is far more informative than the genotype alone. Have the results interpreted by a physician. A healthy lifestyle (diet, exercise, non-smoking) has a much larger impact on life expectancy than any single SNP. Beware of overinterpretation: consumer tests do not provide clinical diagnoses.","area":"gesundheit","canonical_id":"gesundheit:canonical-4f95d84b2b641d516dfb458b","id":"public-46509dba0783815ddeeff52a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechselanalyse | inkl. 28-Tage-Plan & Rezeptbuch in the context of Müdigkeit","score":23.15112421,"snippet":"Your question about an APOB variant in the context of longevity is important. APOB encodes apolipoprotein B, a core component of LDL particles. Genetic variants in APOB can affect LDL clearance and thus modulate cardiovascular risk. However, effect sizes for common SNPs are generally small – they explain only a fraction of the variance. Crucially, a positive finding in a consumer test does not automatically indicate a pathogenic mutation. Many listed 'risk variants' are clinically benign or of uncertain significance. The evidence is human-strong, but based on population-wide association studies, not individual prediction. For your longevity, a fasting lipid panel is far more informative than","sources":[],"title":"Evidence check: DNA Stoffwechselanalyse | inkl. 28-Tage-Plan & Rezeptbuch in the context of Müdigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-46509dba0783815ddeeff52a/evidence-check-dna-stoffwechselanalyse-inkl-28-tage-plan-rezeptbuch-in-the-context-of-muedigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The MyBody-X Cardio Risk Check measures standard lipids (total cholesterol, HDL, LDL, triglycerides) and hsCRP – the same markers a doctor would order in a routine lab. Its value lies in convenience, not in unique or novel biomarkers. In the context of longevity, these parameters are relevant but insufficient: a comprehensive cardiovascular risk assessment for healthy aging should include Lp(a), ApoB, fasting glucose, HbA1c, and possibly genetic risk variants (e.g., 9p21, PCSK9). The test is not diagnostic; abnormal results require medical follow-up. The evidence for the individual markers is strong (human-strong), but the product itself offers no added value over a standard clinical lab test. Marketing often overstates the uniqueness. For longevity planning, a physician-guided risk stratification is recommended.","area":"gesundheit","canonical_id":"gesundheit:canonical-85f01f3cc0553f6c55581d3b","id":"public-9662d7f0779640cb79ab1e26","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of longevity","score":22.36733882,"snippet":"The MyBody-X Cardio Risk Check measures standard lipids (total cholesterol, HDL, LDL, triglycerides) and hsCRP – the same markers a doctor would order in a routine lab. Its value lies in convenience, not in unique or novel biomarkers. In the context of longevity, these parameters are relevant but insufficient: a comprehensive cardiovascular risk assessment for healthy aging should include Lp(a), ApoB, fasting glucose, HbA1c, and possibly genetic risk variants (e.g., 9p21, PCSK9). The test is not diagnostic; abnormal results require medical follow-up. The evidence for the individual markers is strong (human-strong), but the product itself offers no added value over a standard clinical lab tes","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9662d7f0779640cb79ab1e26/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The evidence for LDL cholesterol as a causal risk factor for cardiovascular disease and reduced longevity is very strong. Large randomized trials (e.g., statin studies) and Mendelian randomization consistently show that elevated LDL increases cardiovascular risk, and lowering it reduces events and extends life in high-risk populations. However, the effect on total lifespan is context-dependent. In primary prevention for low-risk individuals, the absolute benefit is smaller. In older adults (>70 years), observational data suggest a U-shaped relationship, where very low LDL may be associated with higher mortality – likely due to reverse causation or frailty, not a direct protective effect. Mechanistically, LDL particles promote atherosclerosis, but particle number (ApoB) and small dense LDL are more atherogenic than total LDL alone. Consumer tests like MyBody-X typically report total LDL, which is useful but incomplete. For longevity, maintaining LDL around 100 mg/dL (2.6 mmol/L) with low inflammation and blood pressure appears optimal. Evidence: human-strong. Caveat: Single LDL values do not predict individual lifespan; comprehensive risk assessment is needed.","area":"gesundheit","canonical_id":"gesundheit:canonical-7d5884cc00a55c1e34b8d130","id":"public-a5988fb9f390ec085a2b4c2e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: LDL in the context of longevity","score":21.33861354,"snippet":"The evidence for LDL cholesterol as a causal risk factor for cardiovascular disease and reduced longevity is very strong. Large randomized trials (e.g., statin studies) and Mendelian randomization consistently show that elevated LDL increases cardiovascular risk, and lowering it reduces events and extends life in high-risk populations. However, the effect on total lifespan is context-dependent. In primary prevention for low-risk individuals, the absolute benefit is smaller. In older adults (>70 years), observational data suggest a U-shaped relationship, where very low LDL may be associated with higher mortality – likely due to reverse causation or frailty, not a direct protective effect. Mec","sources":[],"title":"Evidence check: LDL in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a5988fb9f390ec085a2b4c2e/evidence-check-ldl-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The MyBody-X Cardio Risk Check analyzes DNA markers that, according to the provided context, do not include direct lipid SNPs (LDL, HDL, triglycerides). Instead, genes like PPARGC1A (rs8192678) for aerobic capacity are considered, which may indirectly influence fat metabolism. For precise lipid levels, apoB, and hsCRP, a blood test is essential. The test only offers general lifestyle suggestions, not clinically actionable risk numbers. Regarding longevity: no validated DNA test for lifespan exists; evidence is limited to GWAS with tiny effects (e.g., BDNF rs6265 for BMI). Most associations are population-specific and not replicated. Caveat: consumer tests often overstate significance. Consult a physician for cardiovascular risk assessment and get regular blood work. The test may serve as a motivational tool but does not replace medical diagnostics.","area":"gesundheit","canonical_id":"gesundheit:canonical-d7879f573f91858131a01d76","id":"public-32f494294db2eabf26ecd9d6","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What to watch with Cardio Risk Check | Herz-Kreislauf Risiko-Test and Langlebigkeit?","score":20.24617452,"snippet":"The MyBody-X Cardio Risk Check analyzes DNA markers that, according to the provided context, do not include direct lipid SNPs (LDL, HDL, triglycerides). Instead, genes like PPARGC1A (rs8192678) for aerobic capacity are considered, which may indirectly influence fat metabolism. For precise lipid levels, apoB, and hsCRP, a blood test is essential. The test only offers general lifestyle suggestions, not clinically actionable risk numbers. Regarding longevity: no validated DNA test for lifespan exists; evidence is limited to GWAS with tiny effects (e.g., BDNF rs6265 for BMI). Most associations are population-specific and not replicated. Caveat: consumer tests often overstate significance. Consul","sources":[],"title":"What to watch with Cardio Risk Check | Herz-Kreislauf Risiko-Test and Langlebigkeit?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-32f494294db2eabf26ecd9d6/what-to-watch-with-cardio-risk-check-herz-kreislauf-risiko-test-and-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}